DECIDE Study: Shared decision making for treatment at discharge with schizophrenic inpatients

Not Applicable

Completed

• Conditions: Schizophrenia and schizoaffective disorders; Mental and Behavioural Disorders

• Registration Number: ISRCTN36203678
• Lead Sponsor: Foundation for Biomedical Research Management Cadiz (Fundación para la Gestión de la Investigación Biomedica de Cádiz)

Brief Summary

2020 Interim results article in https://www.cambridge.org/core/journals/european-psychiatry/article/abs/decide-study-effectiveness-of-shared-decision-making-in-treatment-planning-at-discharge-of-inpatient-with-schizophrenia-half-sample-interim-analysis-preliminary-conclusions/65E31372D39180750458AD27697AEE44 (added 02/03/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-07-06
• Study Completion: 2017-06-01
• Last Update Posted: 14 March 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1. Patients aged 18 years and over
2. Diagnosed of schizophrenia (ICD-10: F20) or schizoaffective disorder (ICD-10: F.25)
3. Admitted to Jerez Adult Psychiatric Hospitalization Unit
4. Prescribed antipsychotic medication at discharge

Exclusion Criteria

1. Patients who refuse to sign informed consent
2. Patients who lack capacity in the moment of entering the study,as measured by the Aid to Capacity Evaluation (ACE)
3. Patients with a comorbid diagnosis of severe or moderate mental retardation
4. Patients with poor knowledge or communication skills in Spanish

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Antipsychotic treatment adherence is measured using the Brief Adherence Rating Scale (BARS) and the Drug Attitude Inventory (DAI) at baseline, 3, 6 and 12 months

Secondary Outcome Measures

Name	Time	Method
<br> 1. Readmission rate is measured through medical record review at 3, 6 and 12 months<br> 2. Quality of doctor-patient relationship measured using the Working Alliance Inventory Short Version (WAI-S) at baseline, 3, 6 and 12 months<br> 3. Patient satisfaction with intervention and confidence on decision taken is measured using the Combined Outcome Measure Communication and Treatment Decision making Effectiveness Scale (COMRADE Scale) at baseline, 3, 6 and 12 months<br> 4. Patient perception of hospitalization is measured using the Picker Patient Experience Questionnaire (PPE-15) at discharge<br>